_version_ 1797376268562333696
author Roland Joseph D. Tan
Gary John V. Mercado
Patricia E. Cabrera
Paulita Pamela P. Astudillo
Rolando Enrique D. Domingo
Josept Mari S. Poblete
Charmaine Grace M. Cabebe
Adriel Vincent R. Te
Melissa Anne S. Gonzales
Jocelyn G. Sy
Beltran Alexis A. Aclan
Jayson T. So
Fatima G. Regala
Kimberley Amanda K. Comia
Josemaria M. Castro
Mara Augustine S. Galang
Aldous Dominic C. Cabanlas
Benedicto Juan E. Aguilar
Gabrielle S. Evangelista
Jo Michael Maniwan
Andrei P. Martin
Calvin Y. Martinez
John Alfred H. Lim
Rena Ivy Bascuna
Rachel M. Ng
Kevin B. Agsaoay
Kris Zanna A. Acluba-Arao
Ellaine Rose V. Apostol
Beatriz M. Prieto
author_facet Roland Joseph D. Tan
Gary John V. Mercado
Patricia E. Cabrera
Paulita Pamela P. Astudillo
Rolando Enrique D. Domingo
Josept Mari S. Poblete
Charmaine Grace M. Cabebe
Adriel Vincent R. Te
Melissa Anne S. Gonzales
Jocelyn G. Sy
Beltran Alexis A. Aclan
Jayson T. So
Fatima G. Regala
Kimberley Amanda K. Comia
Josemaria M. Castro
Mara Augustine S. Galang
Aldous Dominic C. Cabanlas
Benedicto Juan E. Aguilar
Gabrielle S. Evangelista
Jo Michael Maniwan
Andrei P. Martin
Calvin Y. Martinez
John Alfred H. Lim
Rena Ivy Bascuna
Rachel M. Ng
Kevin B. Agsaoay
Kris Zanna A. Acluba-Arao
Ellaine Rose V. Apostol
Beatriz M. Prieto
author_sort Roland Joseph D. Tan
collection DOAJ
description AIM: To provide a comprehensive and more representative national data on the disease, especially on treatment options and outcomes, and to determine access of retinoblastoma patients from Luzon, Visayas and Mindanao to eye care, and determine if access is associated with delay in consultation, staging and outcomes. METHODS: Cohort study of retinoblastoma patients seen in eleven institutions located in the three major areas of the Philippines namely Luzon, Vizayas and Mindanao from 2010-2020. RESULTS: Totally 636 patients, involving 821 eyes, were included. Majority (57%) were from Luzon and were seen in institutions in Luzon (72%). Annually, 58±10 new cases were seen with 71% having unilateral disease. Median delay of consultation remained long at 9 (3, 17)mo, longest in patients with unilateral disease (P<0.02) and those from the Visayas (P<0.003). Based on the International Retinoblastoma Staging System, only 35% of patients had Stage 1 while 47% already had extraocular disease. Enucleation was the most common treatment received by 484 patients while intravenous chemotherapy was received by 469. There were 250 (39%) patients alive, 195 (31%) dead, 85 (13%) abandoned, 17 (3%) refused and 89 (14%) with no data. CONCLUSION: This study presents the largest cohort of retinoblastoma patients in the Philippines in terms of patients' and participating institutions' number and geographical location and type of institution (private and public). It also presents more comprehensive data on the treatments used and outcomes (survival, globe salvage, and vision retention rates). Delay in consultation was still long among patients leading to advanced disease stage and lower survival rate. Despite increasing capacity to diagnose and manage retinoblastoma in the country, the delay of consultation remains long primarily due to accessibility issues to eye care institutions especially in the Visayas and financial concerns. The delay was still significant that overall survival rate remain low.
first_indexed 2024-03-08T19:36:05Z
format Article
id doaj.art-1f2161344ff041b6b6466ca2ff49ce42
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-03-08T19:36:05Z
publishDate 2024-01-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-1f2161344ff041b6b6466ca2ff49ce422023-12-26T01:50:00ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982024-01-0117114415610.18240/ijo.2024.01.2020240120Philippine retinoblastoma initiative multi-eye center study 2010-2020Roland Joseph D. Tan0Gary John V. Mercado1Patricia E. Cabrera2Paulita Pamela P. Astudillo3Rolando Enrique D. Domingo4Josept Mari S. Poblete5Charmaine Grace M. Cabebe6Adriel Vincent R. Te7Melissa Anne S. Gonzales8Jocelyn G. Sy9Beltran Alexis A. Aclan10Jayson T. So11Fatima G. Regala12Kimberley Amanda K. Comia13Josemaria M. Castro14Mara Augustine S. Galang15Aldous Dominic C. Cabanlas16Benedicto Juan E. Aguilar17Gabrielle S. Evangelista18Jo Michael Maniwan19Andrei P. Martin20Calvin Y. Martinez21John Alfred H. Lim22Rena Ivy Bascuna23Rachel M. Ng24Kevin B. Agsaoay25Kris Zanna A. Acluba-Arao26Ellaine Rose V. Apostol27Beatriz M. Prieto28Roland Joseph D. Tan. Department of Ophthalmology and Visual Sciences, Sentro Oftalmogico Jose Rizal, Philippine General Hospital, Padre Faura Street, Ermita, Manila 1000, Philippines. olantan385e@yahoo.comDepartment of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila 1000, Philippines; Department of Ophthalmology, Manila Doctors Hospital, Manila 1000, PhilippinesDepartment of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila 1000, Philippines; Department of Ophthalmology, Rizal Medical Center, Pasig City 1600, PhilippinesDepartment of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila 1000, Philippines; Department of Ophthalmology, Jose B. Lingad Memorial Regional Hospital, Pampanga 2000, PhilippinesDepartment of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila 1000, PhilippinesDepartment of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila 1000, PhilippinesDepartment of Ophthalmology, Southern Philippines Medical Center, Davao City 8000, PhilippinesDepartment of Ophthalmology, Southern Philippines Medical Center, Davao City 8000, PhilippinesDepartment of Ophthalmology, Southern Philippines Medical Center, Davao City 8000, PhilippinesDepartment of Ophthalmology, Southern Philippines Medical Center, Davao City 8000, PhilippinesDepartment of Ophthalmology, East Avenue Medical Center, Quezon City 1100, PhilippinesDepartment of Ophthalmology, East Avenue Medical Center, Quezon City 1100, PhilippinesDepartment of Ophthalmology, East Avenue Medical Center, Quezon City 1100, PhilippinesDepartment of Ophthalmology, Manila Doctors Hospital, Manila 1000, PhilippinesDepartment of Ophthalmology, Manila Doctors Hospital, Manila 1000, PhilippinesDepartment of Ophthalmology, Manila Doctors Hospital, Manila 1000, PhilippinesDepartment of Ophthalmology, Northern Mindanao Medical Center, Cagayan de Oro City 9000, PhilippinesDepartment of Ophthalmology, Northern Mindanao Medical Center, Cagayan de Oro City 9000, PhilippinesDepartment of Ophthalmology, Northern Mindanao Medical Center, Cagayan de Oro City 9000, PhilippinesDepartment of Ophthalmology, Rizal Medical Center, Pasig City 1600, PhilippinesDepartment of Ophthalmology, Rizal Medical Center, Pasig City 1600, PhilippinesDepartment of Ophthalmology, Cebu Velez General Hospital, Cebu City 6000, PhilippinesDepartment of Ophthalmology, Cebu Velez General Hospital, Cebu City 6000, PhilippinesLegazpi Eye Center, Legazpi City 4500, PhilippinesLegazpi Eye Center, Legazpi City 4500, PhilippinesDepartment of Ophthalmology, Cagayan Valley Medical Center, Tuguegarao City 3500, PhilippinesDepartment of Ophthalmology, Cagayan Valley Medical Center, Tuguegarao City 3500, PhilippinesDepartment of Ophthalmology, East Avenue Medical Center, Quezon City 1100, PhilippinesDepartment of Ophthalmology, East Avenue Medical Center, Quezon City 1100, PhilippinesAIM: To provide a comprehensive and more representative national data on the disease, especially on treatment options and outcomes, and to determine access of retinoblastoma patients from Luzon, Visayas and Mindanao to eye care, and determine if access is associated with delay in consultation, staging and outcomes. METHODS: Cohort study of retinoblastoma patients seen in eleven institutions located in the three major areas of the Philippines namely Luzon, Vizayas and Mindanao from 2010-2020. RESULTS: Totally 636 patients, involving 821 eyes, were included. Majority (57%) were from Luzon and were seen in institutions in Luzon (72%). Annually, 58±10 new cases were seen with 71% having unilateral disease. Median delay of consultation remained long at 9 (3, 17)mo, longest in patients with unilateral disease (P<0.02) and those from the Visayas (P<0.003). Based on the International Retinoblastoma Staging System, only 35% of patients had Stage 1 while 47% already had extraocular disease. Enucleation was the most common treatment received by 484 patients while intravenous chemotherapy was received by 469. There were 250 (39%) patients alive, 195 (31%) dead, 85 (13%) abandoned, 17 (3%) refused and 89 (14%) with no data. CONCLUSION: This study presents the largest cohort of retinoblastoma patients in the Philippines in terms of patients' and participating institutions' number and geographical location and type of institution (private and public). It also presents more comprehensive data on the treatments used and outcomes (survival, globe salvage, and vision retention rates). Delay in consultation was still long among patients leading to advanced disease stage and lower survival rate. Despite increasing capacity to diagnose and manage retinoblastoma in the country, the delay of consultation remains long primarily due to accessibility issues to eye care institutions especially in the Visayas and financial concerns. The delay was still significant that overall survival rate remain low.http://ies.ijo.cn/en_publish/2024/1/20240120.pdfretinoblastomaphilippinesclinical profile
spellingShingle Roland Joseph D. Tan
Gary John V. Mercado
Patricia E. Cabrera
Paulita Pamela P. Astudillo
Rolando Enrique D. Domingo
Josept Mari S. Poblete
Charmaine Grace M. Cabebe
Adriel Vincent R. Te
Melissa Anne S. Gonzales
Jocelyn G. Sy
Beltran Alexis A. Aclan
Jayson T. So
Fatima G. Regala
Kimberley Amanda K. Comia
Josemaria M. Castro
Mara Augustine S. Galang
Aldous Dominic C. Cabanlas
Benedicto Juan E. Aguilar
Gabrielle S. Evangelista
Jo Michael Maniwan
Andrei P. Martin
Calvin Y. Martinez
John Alfred H. Lim
Rena Ivy Bascuna
Rachel M. Ng
Kevin B. Agsaoay
Kris Zanna A. Acluba-Arao
Ellaine Rose V. Apostol
Beatriz M. Prieto
Philippine retinoblastoma initiative multi-eye center study 2010-2020
International Journal of Ophthalmology
retinoblastoma
philippines
clinical profile
title Philippine retinoblastoma initiative multi-eye center study 2010-2020
title_full Philippine retinoblastoma initiative multi-eye center study 2010-2020
title_fullStr Philippine retinoblastoma initiative multi-eye center study 2010-2020
title_full_unstemmed Philippine retinoblastoma initiative multi-eye center study 2010-2020
title_short Philippine retinoblastoma initiative multi-eye center study 2010-2020
title_sort philippine retinoblastoma initiative multi eye center study 2010 2020
topic retinoblastoma
philippines
clinical profile
url http://ies.ijo.cn/en_publish/2024/1/20240120.pdf
work_keys_str_mv AT rolandjosephdtan philippineretinoblastomainitiativemultieyecenterstudy20102020
AT garyjohnvmercado philippineretinoblastomainitiativemultieyecenterstudy20102020
AT patriciaecabrera philippineretinoblastomainitiativemultieyecenterstudy20102020
AT paulitapamelapastudillo philippineretinoblastomainitiativemultieyecenterstudy20102020
AT rolandoenriqueddomingo philippineretinoblastomainitiativemultieyecenterstudy20102020
AT joseptmarispoblete philippineretinoblastomainitiativemultieyecenterstudy20102020
AT charmainegracemcabebe philippineretinoblastomainitiativemultieyecenterstudy20102020
AT adrielvincentrte philippineretinoblastomainitiativemultieyecenterstudy20102020
AT melissaannesgonzales philippineretinoblastomainitiativemultieyecenterstudy20102020
AT jocelyngsy philippineretinoblastomainitiativemultieyecenterstudy20102020
AT beltranalexisaaclan philippineretinoblastomainitiativemultieyecenterstudy20102020
AT jaysontso philippineretinoblastomainitiativemultieyecenterstudy20102020
AT fatimagregala philippineretinoblastomainitiativemultieyecenterstudy20102020
AT kimberleyamandakcomia philippineretinoblastomainitiativemultieyecenterstudy20102020
AT josemariamcastro philippineretinoblastomainitiativemultieyecenterstudy20102020
AT maraaugustinesgalang philippineretinoblastomainitiativemultieyecenterstudy20102020
AT aldousdominicccabanlas philippineretinoblastomainitiativemultieyecenterstudy20102020
AT benedictojuaneaguilar philippineretinoblastomainitiativemultieyecenterstudy20102020
AT gabriellesevangelista philippineretinoblastomainitiativemultieyecenterstudy20102020
AT jomichaelmaniwan philippineretinoblastomainitiativemultieyecenterstudy20102020
AT andreipmartin philippineretinoblastomainitiativemultieyecenterstudy20102020
AT calvinymartinez philippineretinoblastomainitiativemultieyecenterstudy20102020
AT johnalfredhlim philippineretinoblastomainitiativemultieyecenterstudy20102020
AT renaivybascuna philippineretinoblastomainitiativemultieyecenterstudy20102020
AT rachelmng philippineretinoblastomainitiativemultieyecenterstudy20102020
AT kevinbagsaoay philippineretinoblastomainitiativemultieyecenterstudy20102020
AT kriszannaaaclubaarao philippineretinoblastomainitiativemultieyecenterstudy20102020
AT ellainerosevapostol philippineretinoblastomainitiativemultieyecenterstudy20102020
AT beatrizmprieto philippineretinoblastomainitiativemultieyecenterstudy20102020